Brian Lee, Ph.D., CEO Oct. 12 | 9:45am | Ecolab Life Sciences Ballroom Camarillo, CA (Private) PBS Biotech is a leading manufacturer of single-use bioreactor systems and provider of process development services. PBS bioreactors utilize proprietary Vertical-Wheel® technology to create homogeneous and scalable mixing conditions for a variety of...
David Main, President and CEO Oct. 10 | 11:00am | Rentschler ATMP Ballroom Vancouver, BC (Private) Notch is working to broaden the applicability and increase accessibility of cell therapy as a medicine through our unprecedented production of functional T cells from iPSCs and our proprietary, scalable, small-footprint manufacturing systems...
Sarah Meeks, Senior Vice President, Business Development Oct. 11 | 5:30pm | Rentschler ATMP Ballroom Rockville, MD (NASDAQ: MXCT) MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative, cell-based research. MaxCyte builds best-in-class...
Sean Ainsworth, Chief Executive Officer and Chairman of the Board Oct. 12 | 9:45am | Rentschler ATMP Ballroom Seattle, WA (Private) Immusoft is developing a cutting-edge approach to sustained delivery of protein therapeutics using a patient’s own cells. The approach is called Immune System Programming (ISP™). ISP entails...
Tim Miller, Ph.D., CEO, President, and Co-Founder Oct. 10 | 5:00pm | Ecolab Life Sciences Ballroom Grove City, OH (Private) Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring...
Seth Ettenberg, Ph.D., CEO Oct. 11 | 10:00am | Ecolab Life Sciences Ballroom Cambridge, MA (Private) In-person Presentation BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines...
Robert Mays, Ph.D., Executive Vice President Oct. 11 | 10:45am | Ecolab Life Sciences Ballroom Cleveland, OH (NASDAQ: ATHX) Athersys is a clinical-stage biotechnology company developing novel and proprietary best-in-class therapies designed to extend and enhance the quality of human life. Our focus is on the treatment of medical...
Devyn Smith, Ph.D., CEO Oct. 11 | 11:00am | Ecolab Life Sciences Ballroom Cambridge, MA (Private) Arbor Biotechnologies is a life sciences company discovering and developing the next generation of genetic medicines based on wholly owned genomic editors discovered from its machine learning/AI driven discovery platform. Since its founding...
Todd Howren, Ph.D., Vice President, RNA Client Services Oct. 10 | 10:15am | Ecolab Life Sciences Ballroom Fargo, ND (NASDAQ: DHR) Aldevron serves the biotechnology industry with custom production of nucleic acids and proteins. Thousands of clients use Aldevron-produced plasmids, RNA and gene editing enzymes for projects ranging from...
Matt Britz, President and Chief Operating Officer Oct. 10 | 5:00pm | Rentschler ATMP Ballroom Natick, MA (Private) AffyImmune is realizing the potential of cancer immunotherapy by extending the anti-cancer activity of CAR T cell therapy to solid tumors. AffyImmune’s proprietary technology allows fine-tuning of the affinity of CAR...
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
October 7-9, 2024
Arizona Biltmore
Phoenix, AZ
